Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 2 , Pages 265-276, June 2007

The importance of thyroid hormone transporters for brain development and function

  • Heike Heuer (Junior Research Group Leader)

      Affiliations

    • Corresponding Author InformationTel.: +49 3641 65 6021; Fax: +49 3641 65 6040.

Leibniz Institute for Age Research/Fritz Lipmann Institute, Beutenbergstrasse 11, D-07745 Jena, Germany

Thyroid hormone is essential for proper brain development and function. As a prerequisite for its action, transporters must exist to mediate its cellular entry. As impaired uptake of thyroid hormone into the CNS causes severe neurological symptoms, it is of utmost importance to identify these carriers. The monocarboxylate transporter 8 (MCT8) was recently characterized as a very specific thyroid hormone transporter. Inactivating mutations in the MCT8 gene are associated with a severe syndrome of psychomotor retardation and abnormal thyroid hormone parameters. To elucidate the underlying pathogenic mechanisms, MCT8-deficient mice that replicate the human thyroid phenotype, despite the absence of overt neurological symptoms, have been generated. Here, we summarize recent findings obtained by analyzing these animals and discuss their potential impact for the treatment of affected patients.

Key words: iodothyronine deiodinases, MCT8, OATP1c1, X-linked psychomotor retardation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(07)00024-3

doi:10.1016/j.beem.2007.03.003

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 2 , Pages 265-276, June 2007